Medical Marijuana, Inc. announced today that its subsidiary HempMeds® Mexico, the first company to receive government import permits for the cannabidiol (CBD) oil product RSHO-X™ via the Mexican Health Department COFEPRIS was featured in a Dope Magazine article highlighting the Company’s role in fueling less restrictive medical cannabis programs in Mexico.
The March 3, 2017, article titled “Mexico’s Evolving Stance on Marijuana” discusses how the plight of one young Mexican girl led Mexico’s government to allow Medical Marijuana, Inc.’s hemp-based CBD oil RSHO-X™ across its border. The article also describes how Medical Marijuana, Inc. has been instrumental in the acceptance and legalization of cannabis products across other Latin American countries including Brazil, Paraguay and Chile – with its exports of Real Scientific Hemp Oil™ (RSHO™) and the THC-free alternative, RSHO-X™.
“This recent article in Dope Magazine shows how the world is opening their eyes to the many therapeutic benefits of medical cannabis,” said Chief Executive Officer of Medical Marijuana, Inc. Dr. Stuart Titus. “We are proud to be recognized as the only Company with legal cannabis-based products allowed to be imported into Mexico. As the tide of opinion regarding medical cannabis continues to change in Mexico and Latin America, we will continue to work alongside lawmakers, doctors and patients in effort to bring access to those who need it most.”
Recent clinical data from epilepsy studies performed in Mexico by Dr’s. Carlos Aguirre and Saul Garza Morales show the beneficial aspects of botanical CBD vs the pharmaceutical version. Improvements in overall seizure reduction were shown to significantly favor the botanical CBD version over the pharma developed alternative – all with zero side effects. The pharma product has been experiencing a 30% adverse side effect detriment to where many families and children have had to discontinue with the pharma-based studies.
The Dope Magazine article also states that HempMeds® now treats “upwards of 1,500 families with epileptic children in Brazil alone,” as acceptance of CBD as a legitimate medical treatment for a growing number of illnesses continues to grow.
Comments are closed.